Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 9/20 | 0.56 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.56 |
| ▸ | GGH | Q92820 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15847346 | 1.00 | NAALAD2 (0.57) | NAALAD2FOLH1RIMKLAGGHCYP1A2 | |
| SCHEMBL15846661 | 0.90 | NAALAD2 (0.54) | NAALAD2FOLH1RIMKLAGGHCYP1A2 | |
| SCHEMBL15846663 | 0.90 | NAALAD2 (0.54) | NAALAD2FOLH1RIMKLAGGHCYP1A2 | |
| SCHEMBL18739860 | 0.89 | MME (0.50) | NAALAD2FOLH1RIMKLANOD1ACE | |
| SCHEMBL15846359 | 0.89 | NAALAD2 (0.53) | NAALAD2FOLH1RIMKLAGGHNOD1 | |
| SCHEMBL15846358 | 0.89 | NAALAD2 (0.53) | NAALAD2FOLH1RIMKLAGGHNOD1 | |
| SCHEMBL15847003 | 0.88 | NAALAD2 (0.63) | NAALAD2FOLH1RIMKLAGGHCYP1A2 | |
| SCHEMBL15847005 | 0.88 | NAALAD2 (0.63) | NAALAD2FOLH1RIMKLAGGHCYP1A2 | |
| SCHEMBL15846509 | 0.87 | NOD1 (0.54) | NAALAD2FOLH1RIMKLANOD1 | |
| SCHEMBL15847222 | 0.87 | NOD1 (0.54) | NAALAD2FOLH1RIMKLANOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770652-B2 | ANTITUMOR AGENTS COMPRISING A PYRROLO(2,3-D) PYRIMIDINE COMPOUNDS | DUQUESNE UNIVERSITY OF THE HOLY GHOST | 2004-08-03 | — | — | US | claimed |
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | L'OREAL (FR) | 2022-02-15 | — | — | US | disclosed |
| US-10772823-B2 | Molecularly imprinted polymer for selectively trapping odorous molecules | L'OREAL (FR) | 2020-09-15 | — | — | US | disclosed |
| EP-2938654-B1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | OREAL (FR) | 2016-08-24 | — | — | EP | disclosed |
| US-20150342868-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | LOREAL (FR) | 2015-12-03 | — | — | US | disclosed |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-12 | — | — | US | disclosed |
| EP-2938402-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | disclosed |
| EP-2938654-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2015-11-04 | — | — | EP | disclosed |
| WO-2014102077-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014102078-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | L'OREAL (FR) | 2014-07-03 | — | — | WO | disclosed |
| CN-1784209-B | stick composition | UNILEVER NV | 2010-06-09 | — | — | CN | disclosed |
| CN-1784209-A | stick composition | UNILEVER PLC (GB) | 2006-06-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | TAS2R30, TAS1R1, TAS2R10 | NAALAD2 3108/4885FOLH1 4864/4885RIMKLA 4327/4885 |
| US-20150342868-A1 | MOLECULARLY IMPRINTED POLYMER OF SOL-GEL TYPE FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | TAS2R30, TAS1R1, TAS2R10 | NAALAD2 3108/4885FOLH1 4864/4885RIMKLA 4327/4885 |
| US-10772823-B2 | Molecularly imprinted polymer for selectively trapping odorous molecules | OR10J3, OR51E2, MSMO1 | NAALAD2 3776/4885FOLH1 4778/4885RIMKLA 4079/4885 |
| US-20150320667-A1 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES | OR10J3, OR51E2, MSMO1 | NAALAD2 3776/4885FOLH1 4778/4885RIMKLA 4079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.